Format

Send to

Choose Destination
See comment in PubMed Commons below
Risk Manag Healthc Policy. 2008;1:15-21. doi: 10.2147/RMHP.S4500. Epub 2008 Nov 24.

The costs of breast cancer in a Mexican public health institution.

Author information

  • 1Universidad Autónoma Metropolitano-Xochimilco (UAM-X), Departments: Biological Systems and Healthcare, Biological and Health Sciences Division (DCBS).

Abstract

Breast cancer (BC) is the second leading cause of death as a result of neoplasia in Mexico. This study aimed to identify the direct and indirect costs of treating female outpatients diagnosed with BC at a Mexican public hospital. A cross-sectional, observational, analytical study was conducted. A total of 506 medical records were analyzed and 102 were included in the cost analysis. The micro-costing process was used to estimate treatment costs. A 17-item questionnaire was used to obtain information on direct and indirect costs. Of the 102 women with BC included in the study, 92.2% (94) were at Stage II, and only 7.8% at Stage I. Total direct costs over six months for the 82 women who had modified radical mastectomy (MRM) surgury were US$733,821.15. Total direct costs for the 15 patients with conservative surgery (CS) were US$138,190.39. We found that the total economic burden in the study population was much higher for patients with MRM than for patients with CS.

KEYWORDS:

Mexican women; breast cancer; direct and indirect costs

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk